Arkolith/Insider Trading/LJPC/Form 4

Johnson Laura L.

DirectorLA JOLLA PHARMACEUTICAL CO (LJPC) · full profile →Form 4 · filed Aug 24, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
11
1 non-derivative · 10 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 22, 2022Disposed to issuer(D)500$6.23$3K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 22, 2022Disposed to issuer(D)14K——0
Aug 22, 2022Disposed to issuer(D)30K——0
Aug 22, 2022Disposed to issuer(D)30K——0
Aug 22, 2022Disposed to issuer(D)12K——0
Aug 22, 2022Disposed to issuer(D)12K——0
Aug 22, 2022Disposed to issuer(D)10K——0
Aug 22, 2022Disposed to issuer(D)10K——0
Aug 22, 2022Disposed to issuer(D)10K——0
Aug 22, 2022Disposed to issuer(D)10K——0
Aug 22, 2022Disposed to issuer(D)13K——0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-029651) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML